Table of contents

September 2005 Volume 2 No 9

Top

Editorial

Should the FDA be the doctor of last resort?

Vincent T DeVita Jr

423

doi:10.1038/ncponc0292 | Full Text | PDF (45K)

Top

Viewpoints

Mortality and survival in breast and colorectal cancer

Peter Boyle and Jacques Ferlay

424

doi:10.1038/ncponc0288 | Full Text | PDF (69K)

Phase III trials in oncology: setting standards of care?

Siegfried Seeber and Ada H Braun

426

doi:10.1038/ncponc0284 | Full Text | PDF (75K)

Top

Research Highlights

Laparoscopic bowel resection: comparable efficacy to that of open surgery in patients with colon cancer

Alexandra King

428

doi:10.1038/ncponc0241 | Full Text | PDF (64K)

TP53 mutations as a prognostic factor in women with breast cancer

Marie Lofthouse

428

doi:10.1038/ncponc0243 | Full Text | PDF (71K)

Effective early evaluation of isolated limb perfusion in the treatment of limb sarcoma

Alexandra King

428

doi:10.1038/ncponc0257 | Full Text | PDF (64K)

Predicting outcome after preoperative therapy for rectal cancer

Rebecca Doherty

429

doi:10.1038/ncponc0255 | Full Text | PDF (61K)

Response of malignant gliomas to erlotinib

Rebecca Ireland

429

doi:10.1038/ncponc0256 | Full Text | PDF (74K)

96-hour infusion of paclitaxel in advanced bronchioloalveolar carcinoma

Rachel Murphy

430

doi:10.1038/ncponc0258 | Full Text | PDF (64K)

Promoter methylation reduces expression of TGF-beta receptor type 2 gene in prostate cancer

Claire Braybrook

430

doi:10.1038/ncponc0259 | Full Text | PDF (73K)

Prognostic role of survivin expression in pancreatic cancer

Katy Cherry

431

doi:10.1038/ncponc0260 | Full Text | PDF (63K)

A novel biomarker with high sensitivity for hepatocellular carcinoma

Alexandra King

431

doi:10.1038/ncponc0261 | Full Text | PDF (63K)

Novel method for distinguishing between metastatic and benign pheochromocytoma

Rebecca Ireland

431

doi:10.1038/ncponc0262 | Full Text | PDF (71K)

GVT effect of reduced-intensity allogeneic transplantation for Hodgkin's lymphoma

Marie Lofthouse

432

doi:10.1038/ncponc0264 | Full Text | PDF (60K)

Darbepoetin alfa: an effective treatment for chemotherapy-related anemia

Alexandra King

432

doi:10.1038/ncponc0265 | Full Text | PDF (68K)

The origins of multifocal papillary thyroid tumors

Christine Kyme

433

doi:10.1038/ncponc0266 | Full Text | PDF (58K)

Top

Practice Points

Do cyclo-oxygenase 2 inhibitors increase the risk of cardiovascular events?

Andrew T Chan and Charles S Fuchs

434

doi:10.1038/ncponc0291 | Full Text | PDF (74K)

Can axillary radiotherapy replace axillary dissection for early-stage breast cancer?

Farin F Amersi and Armando E Giuliano

436

doi:10.1038/ncponc0290 | Full Text | PDF (73K)

Is radiofrequency ablation effective in patients with early-stage hepatocellular carcinoma and cirrhosis?

S Nahum Goldberg

438

doi:10.1038/ncponc0285 | Full Text | PDF (70K)

What are the long-term effects of chemotherapy and hormonal therapy for early breast cancer?

Aron Goldhirsch, Richard D Gelber and Alan S Coates

440

doi:10.1038/ncponc0296 | Full Text | PDF (72K)

Does postmastectomy radiation reduce mortality in women with stage T1–2 node-positive breast cancer?

Ruth Heimann

442

doi:10.1038/ncponc0289 | Full Text | PDF (70K)

Does treatment with recombinant human erythropoietin affect the survival of anemic patients with cancer?

David P Steensma and Thomas E Witzig

444

doi:10.1038/ncponc0283 | Full Text | PDF (71K)

Can docetaxel dosing be individualized based on cytochrome p450 activity?

Chris H Takimoto

446

doi:10.1038/ncponc0269 | Full Text | PDF (74K)

Top

Reviews

Should sentinel lymph-node biopsy be used routinely for staging melanoma and breast cancers?

Charles R Scoggins, Anees B Chagpar, Robert CG Martin and Kelly M McMasters

448

doi:10.1038/ncponc0293 | Full Text | PDF (414K)

New concepts for phase I trials: evaluating new drugs combined with radiation therapy

Eric Deutsch, Jean Charles Soria and Jean Pierre Armand

456

doi:10.1038/ncponc0295 | Full Text | PDF (302K)

Primer: an evidence-based approach to prognostic markers

Douglas G Altman and Richard D Riley

466

doi:10.1038/ncponc0287 | Full Text | PDF (137K)

Top

Case Study

Continuing Medical Education

Long-term complete remission of laryngeal Kaposi's sarcoma after palliative radiotherapy

Carmen Ares and Abdelkarim S Allal

473

doi:10.1038/ncponc0294 | Full Text | PDF (128K)

Extra navigation

.

ADVERTISEMENT